{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:34:35Z","timestamp":1793421275232,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82388101"],"award-info":[{"award-number":["82388101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271122"],"award-info":[{"award-number":["82271122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biobank Project of Shanghai Ninth People\u2019s Hospital","award":["YBKB202211"],"award-info":[{"award-number":["YBKB202211"]}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20DZ2270800"],"award-info":[{"award-number":["20DZ2270800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Key Clinical Specialty, Shanghai Eye Disease Research Center","award":["2022ZZ01003"],"award-info":[{"award-number":["2022ZZ01003"]}]},{"name":"Shanghai Municipal Commission of Health and Family Planning Project","award":["2022XD006"],"award-info":[{"award-number":["2022XD006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04367-9","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T02:51:14Z","timestamp":1753325474000},"page":"719-729","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effectiveness of intravenous glucocorticoids in active thyroid eye disease patients with low clinical activity scores"],"prefix":"10.1007","volume":"90","author":[{"given":"Haiyang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5666-6894","authenticated-orcid":false,"given":"Xuefei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9394-3969","authenticated-orcid":false,"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8636-861X","authenticated-orcid":false,"given":"Huifang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"issue":"5","key":"4367_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/joim.13524","volume":"292","author":"L Bartalena","year":"2022","unstructured":"L. Bartalena, M.L. Tanda, Current concepts regarding Graves\u2019 orbitopathy. J. Intern. Med. 292(5), 692\u2013716 (2022). https:\/\/doi.org\/10.1111\/joim.13524.","journal-title":"J. Intern. Med."},{"key":"4367_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.615993","volume":"11","author":"L Bartalena","year":"2020","unstructured":"L. Bartalena, E. Piantanida, D. Gallo et al., Epidemiology, natural history, risk factors, and prevention of Graves\u2019 orbitopathy. Front. Endocrinol. 11, 615993 (2020). https:\/\/doi.org\/10.3389\/fendo.2020.615993.","journal-title":"Front. Endocrinol."},{"key":"4367_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/eye.2012.284","volume":"27","author":"DH Verity","year":"2013","unstructured":"D.H. Verity, G.E. Rose, Acute thyroid eye disease (TED): principles of medical and surgical management. Eye 27, 308\u2013319 (2013). https:\/\/doi.org\/10.1038\/eye.2012.284.","journal-title":"Eye"},{"key":"4367_CR4","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"L. Bartalena, G.J. Kahaly, L. Baldeschi et al., The 2021 European group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur. J. Endocrinol. 185, G43\u2013G67 (2021). https:\/\/doi.org\/10.1530\/EJE-21-0479.","journal-title":"Eur. J. Endocrinol."},{"key":"4367_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/bjo.73.8.639","volume":"73","author":"MP Mourits","year":"1989","unstructured":"M.P. Mourits, L. Koornneef, W.M. Wiersinga et al., Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach. Br. J. Ophthalmol. 73, 639\u2013644 (1989). https:\/\/doi.org\/10.1136\/bjo.73.8.639.","journal-title":"Br. J. Ophthalmol."},{"key":"4367_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1742-1241.2006.01004.x","volume":"61","author":"S Aktaran","year":"2007","unstructured":"S. Aktaran, E. Akarsu, I. Erba\u011fci et al., Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves\u2019 ophthalmopathy. Int. J. Clin. Pract. 61, 45\u201351 (2007). https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01004.x.","journal-title":"Int. J. Clin. Pract."},{"key":"4367_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/thy.1998.8.539","volume":"8","author":"CA Gorman","year":"1998","unstructured":"C.A. Gorman, The measurement of change in Graves\u2019 ophthalmopathy. Thyroid 8, 539\u2013543 (1998). https:\/\/doi.org\/10.1089\/thy.1998.8.539.","journal-title":"Thyroid"},{"key":"4367_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12020-022-03193-7","volume":"79","author":"R Parameswaran","year":"2022","unstructured":"R. Parameswaran, M.C. De Jong, J.L.W. Kit et al., 2021 Asia-pacific Graves\u2019 disease consortium survey of clinical practice patterns in the management of Graves\u2019 disease. Endocrine 79, 135\u2013142 (2022). https:\/\/doi.org\/10.1007\/s12020-022-03193-7.","journal-title":"Endocrine"},{"key":"4367_CR9","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.4103\/ijo.IJO_3217_21","volume":"70","author":"CY Yu","year":"2022","unstructured":"C.Y. Yu, R.L. Ford, S.T. Wester et al., Update on thyroid eye disease: regional variations in prevalence, diagnosis, and management. Indian. J. Ophthalmol. 70, 2335\u20132345 (2022). https:\/\/doi.org\/10.4103\/ijo.IJO_3217_21.","journal-title":"Indian. J. Ophthalmol."},{"key":"4367_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.eprac.2020.09.008","volume":"27","author":"X Liu","year":"2021","unstructured":"X. Liu, Y. Su, M. Jiang et al., Application of magnetic resonance imaging in the evaluation of disease activity in Graves\u2019 ophthalmopathy. Endocr. Pract. 27, 198\u2013205 (2021). https:\/\/doi.org\/10.1016\/j.eprac.2020.09.008.","journal-title":"Endocr. Pract."},{"key":"4367_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-021-00895-3","volume":"21","author":"Q Ge","year":"2021","unstructured":"Q. Ge, X. Zhang, L. Wang et al., Quantitative evaluation of activity of thyroid-associated ophthalmopathy using short-tau inversion recovery (STIR) sequence. BMC Endocr. Disord. 21, 226 (2021). https:\/\/doi.org\/10.1186\/s12902-021-00895-3.","journal-title":"BMC Endocr. Disord."},{"key":"4367_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1259\/0007-1285-67-795-244","volume":"67","author":"RD Laitt","year":"1994","unstructured":"R.D. Laitt, B. Hoh, C. Wakeley et al., The value of the short tau inversion recovery sequence in magnetic resonance imaging of thyroid eye disease. Br. J. Radiol. 67, 244\u2013247 (1994). https:\/\/doi.org\/10.1259\/0007-1285-67-795-244.","journal-title":"Br. J. Radiol."},{"key":"4367_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejrad.2005.03.027","volume":"56","author":"EJ Mayer","year":"2005","unstructured":"E.J. Mayer, D.L. Fox, G. Herdman et al., Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease. Eur. J. Radiol. 56, 20\u201324 (2005). https:\/\/doi.org\/10.1016\/j.ejrad.2005.03.027.","journal-title":"Eur. J. Radiol."},{"key":"4367_CR14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/eye.2001.102","volume":"15","author":"E Mayer","year":"2001","unstructured":"E. Mayer, G. Herdman, C. Burnett et al., Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid eye disease. Eye 15, 313\u2013318 (2001). https:\/\/doi.org\/10.1038\/eye.2001.102.","journal-title":"Eye"},{"key":"4367_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000510700","volume":"9","author":"L Bartalena","year":"2020","unstructured":"L. Bartalena, W.M. Wiersinga, Proposal for standardization of primary and secondary outcomes in patients with active, moderate-to-severe Graves\u2019 orbitopathy. Eur. Thyroid. J. 9, 3\u201316 (2020). https:\/\/doi.org\/10.1159\/000510700.","journal-title":"Eur. Thyroid. J."},{"key":"4367_CR16","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.21037\/qims-22-814","volume":"13","author":"J Cheng","year":"2023","unstructured":"J. Cheng, X. Zhang, J. Lian et al., Evaluation of activity of Graves\u2019 orbitopathy with multiparameter orbital magnetic resonance imaging (MRI). Quant. Imaging Med. Surg. 13, 3040\u20133049 (2023). https:\/\/doi.org\/10.21037\/qims-22-814.","journal-title":"Quant. Imaging Med. Surg."},{"key":"4367_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ophtha.2011.07.011","volume":"119","author":"PJ Dolman","year":"2012","unstructured":"P.J. Dolman, K. Cahill, C.N. Czyz et al., Reliability of estimating ductions in thyroid eye disease: an international thyroid eye disease society multicenter study. Ophthalmology 119, 382\u2013389 (2012). https:\/\/doi.org\/10.1016\/j.ophtha.2011.07.011.","journal-title":"Ophthalmology"},{"key":"4367_CR18","doi-asserted-by":"publisher","first-page":"20200884","DOI":"10.1259\/bjr.20200884","volume":"94","author":"L Chen","year":"2021","unstructured":"L. Chen, H. Hu, H.-H. Chen et al., Usefulness of two-point dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance. Br. J. Radiol. 94, 20200884 (2021). https:\/\/doi.org\/10.1259\/bjr.20200884.","journal-title":"Br. J. Radiol."},{"key":"4367_CR19","doi-asserted-by":"publisher","first-page":"e220260","DOI":"10.1530\/EC-22-0260","volume":"11","author":"X Zhang","year":"2022","unstructured":"X. Zhang, C. Han, H. Wang et al., The correlation of the neutrophil-lymphocyte ratio to clinical and imaging parameters in patients with thyroid eye disease. Endocr. Connect. 11, e220260 (2022). https:\/\/doi.org\/10.1530\/EC-22-0260.","journal-title":"Endocr. Connect."},{"key":"4367_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/197140091302600509","volume":"26","author":"F Tortora","year":"2013","unstructured":"F. Tortora, M. Cirillo, M. Ferrara et al., Disease activity in Graves\u2019 ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score. Neuroradiol. J. 26, 555\u2013564 (2013). https:\/\/doi.org\/10.1177\/197140091302600509.","journal-title":"Neuroradiol. J."},{"key":"4367_CR21","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s11596-017-1831-8","volume":"37","author":"K Hou","year":"2017","unstructured":"K. Hou, T. Ai, W. Hu et al., Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves\u2019 ophthalmopathy. Curr. Med. Sci. 37, 938\u2013942 (2017). https:\/\/doi.org\/10.1007\/s11596-017-1831-8.","journal-title":"Curr. Med. Sci."},{"key":"4367_CR22","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1507\/endocrj.K10E-156","volume":"57","author":"S Tachibana","year":"2010","unstructured":"S. Tachibana, T. Murakami, H. Noguchi et al., Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves\u2019 ophthalmopathy. Endocr. J. 57, 853\u2013861 (2010). https:\/\/doi.org\/10.1507\/endocrj.K10E-156.","journal-title":"Endocr. J."},{"key":"4367_CR23","doi-asserted-by":"publisher","first-page":"20201215","DOI":"10.1259\/bjr.20201215","volume":"94","author":"MT Cashmore","year":"2021","unstructured":"M.T. Cashmore, A.J. McCann, S.J. Wastling et al., Clinical quantitative MRI and the need for metrology. Br. J. Radiol. 94, 20201215 (2021). https:\/\/doi.org\/10.1259\/bjr.20201215.","journal-title":"Br. J. Radiol."},{"key":"4367_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/jmri.24776","volume":"42","author":"HS Kim","year":"2015","unstructured":"H.S. Kim, K.S. Lee, Y. Ohno et al., PET\/CT versus MRI for diagnosis, staging, and follow-up of lung cancer: PET\/CT versus MRI in lung cancer. J. Magn. Reson. Imaging 42, 247\u2013260 (2015). https:\/\/doi.org\/10.1002\/jmri.24776.","journal-title":"J. Magn. Reson. Imaging"},{"key":"4367_CR25","doi-asserted-by":"publisher","first-page":"20140677","DOI":"10.1259\/bjr.20140677","volume":"88","author":"R Kilicarslan","year":"2015","unstructured":"R. Kilicarslan, A. Alkan, M.M. Ilhan et al., Graves\u2019 ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease. Br. J. Radiol. 88, 20140677 (2015). https:\/\/doi.org\/10.1259\/bjr.20140677.","journal-title":"Br. J. Radiol."},{"key":"4367_CR26","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1136\/bjophthalmol-2015-306733","volume":"99","author":"P Perros","year":"2015","unstructured":"P. Perros, M. \u017darkovi\u0107, C. Azzolini et al., PREGO (presentation of Graves\u2019 orbitopathy) study: changes in referral patterns to European group on Graves\u2019 orbitopathy (EUGOGO) centres over the period from 2000 to 2012. Br. J. Ophthalmol. 99, 1531\u20131535 (2015). https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306733.","journal-title":"Br. J. Ophthalmol."},{"key":"4367_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/bjo-2024-325346","volume":"109","author":"KKH Lai","year":"2025","unstructured":"K.K.H. Lai, F.M.A.A. Aljufairi, J.U. Sebastian et al., Low clinical activity score, \u201cprogressive\u201d thyroid eye disease: presentations of 1439 patients from a tertiary centre in Hong Kong. Br. J. Ophthalmol. 109, 715\u2013720 (2025). https:\/\/doi.org\/10.1136\/bjo-2024-325346.","journal-title":"Br. J. Ophthalmol."},{"key":"4367_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-88142-w","volume":"15","author":"H Zhang","year":"2025","unstructured":"H. Zhang, W. He, A curative effect evaluation of intensity-modulated radiation therapy combined with periorbital triamcinolone acetonide injection in treating thyroid eye disease patients with active extraocular muscle but low CAS. Sci. Rep. 15, 3222 (2025). https:\/\/doi.org\/10.1038\/s41598-025-88142-w.","journal-title":"Sci. Rep."},{"key":"4367_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1210\/jc.2014-3014","volume":"100","author":"M Salvi","year":"2015","unstructured":"M. Salvi, G. Vannucchi, N. Curr\u00f2 et al., Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves\u2019 orbitopathy: a randomized controlled study. J. Clin. Endocrinol. Metab. 100, 422\u2013431 (2015). 2015020611555000619.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4367_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S2213-8587(18)30020-2","volume":"6","author":"GJ Kahaly","year":"2018","unstructured":"G.J. Kahaly, M. Riedl, J. K\u00f6nig et al., Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves\u2019 orbitopathy (MINGO): a randomised, observer-masked, multicentre trial. Lancet Diabetes Endocrinol. 6, 287\u2013298 (2018). https:\/\/doi.org\/10.1016\/S2213-8587(18)30020-2.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4367_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-9-6","volume":"9","author":"R Rajendram","year":"2008","unstructured":"R. Rajendram, R.W.J. Lee, M.J. Potts et al., Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial. Trials 9, 6 (2008). https:\/\/doi.org\/10.1186\/1745-6215-9-6.","journal-title":"Trials"},{"key":"4367_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1210\/jc.2014-2572","volume":"100","author":"MN Stan","year":"2015","unstructured":"M.N. Stan, J.A. Garrity, B.G. Carranza Leon et al., Randomized controlled trial of rituximab in patients with Graves\u2019 orbitopathy. J. Clin. Endocrinol. Metab. 100, 432\u2013441 (2015). 2015020611555000619.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4367_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38640-5","volume":"9","author":"M Ito","year":"2019","unstructured":"M. Ito, Y. Takahashi, E. Katsuda et al., Predictive factors of prognosis after radiation and steroid pulse therapy in thyroid eye disease. Sci. Rep. 9, 2027 (2019). https:\/\/doi.org\/10.1038\/s41598-019-38640-5.","journal-title":"Sci. Rep."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04367-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04367-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04367-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:07:23Z","timestamp":1761736043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04367-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4367"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04367-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This retrospective study was approved by the ethics committee of the hospital (SH9H-2022-T161-2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Given the retrospective nature of the study, the requirement for informed consent was waived. However, during the treatment process, potential adverse effects of the current treatment regimen were thoroughly discussed with the patients, who voluntarily agreed to participate after confirming the absence of contraindications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Fig.\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}